Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesAssociation of catechol-o-methyl transferase gene polymorphism with prostate
Journal of Research in Medical Sciences, 08/05/09
Omrani MD et al. – Decreased level of catechol–o–methyl transferase gene activity may play a possible role in benign prostatic hyperplasia development but not in prostate cancer. Increased level of COMT gene activity has a protective role against BPH.
Related Articles
Routine evaluation of prostate size not as effective in cancer screening
EurekAlert, 11/11/09
Relevance Score: 95%
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/16/09
Relevance Score: 95%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 95%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 94%
Exercise and Prostate Cancer Risk in a Cohort of Veterans Undergoing Prostate Needle Biopsy
The Journal of Urology, 10/19/09
Relevance Score: 93%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model
BJU International, 11/30/09
Analysis of Polymorphisms in the SRD5A2 Gene and Semen Parameters in Estonian Men
Journal of Andrology, 11/24/09
CD10 expression in urothelial carcinoma of the bladder
Diagnostic Pathology, 11/23/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model
BJU International, 11/30/09
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
European Urology, 11/30/09
Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life
Prostate Cancer & Prostatic Diseases, 11/30/09
Article Search
Sponsor